T-Cell Recognition of Pre-S Regions of HBsAg can Bypass Nonresponse to the S Region

  • David R. Milich
  • Alan McLachlan
  • George B. Thornton
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 225)


The specific serologic marker of hepatitis B virus (HBV) infection is the hepatitis B surface antigen (HBsAg), which is present both in the intact virion and as free circulating filamentous and spherical 22-nm particles. The HBsAg is composed of a major polypeptide, p25, and its glycosylated form, gp28. However, additional polypeptides of higher m.w. (p39/gp42 and gp33/gp36) have been identified associated preferentially with the intact virion and the filamentous form of 22-nm particles (1). The p25 polypeptide is encoded by the S gene beginning from the third possible translational initiation site of a larger open reading frame (ORF) and is preceded in phase by 174 codons (adw subtype) designated the pre-S region (2). The large ORF for HBsAg terminates in a single stop codon but can initiate at three possible translational start codons, which define the pre-S(1), pre-S(2), and S regions, yielding p39, p33, and p25, respectively. All three polypeptides share the 226 amino acid residues of the S region (p25); p33 consists of the p25 sequence plus an amino-terminal 55 residues [pre-S(2)] (3) and p39 consists of the p33 sequence plus an amino-terminal 119 residues [pre-S(1)] (1) (see Fig. 1). Therefore, three different envelope polypeptides are expressed by the variable use of initiation codons in one ORF, and HBsAg-containing virions or particles may vary in composition relative to these three polypeptides. Herein, we designate purified HBsAg particle preparations by virtue of the highest m.w. polypeptide present (i.e. HBsAg/p39, HBsAg/p33, and HBsAg/p25).


Antibody Binding Site Cell Proliferative Response Intact Virion Large Open Reading Frame Murine Strain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Heermann, K.H., Goldman, U., Schwartz, W., Seyffarth, T., Baumgarten, J., and Gerlich, W.H. 1984. J. Virol. 52: 396.PubMedGoogle Scholar
  2. 2.
    Tiollaís, P., Charnay, P., and Vyas, G.N. 1981. Science 213: 406.PubMedCrossRefGoogle Scholar
  3. 3.
    Stibbe, W., and Gerlich, W.H. 1983. J. Virol. 46: 626.PubMedGoogle Scholar
  4. 4.
    Neurath, A.R., Kent, S.B.H., and Strick, N. 1984. Science 224: 392.PubMedCrossRefGoogle Scholar
  5. 5.
    Milich, D.R., Thornton, G.B., Neurath, A., Kent, S., Michel, M., Tiollais, P., and Chisari, F.V. 1985. Science 228: 1195.PubMedCrossRefGoogle Scholar
  6. 6.
    Vyas, G.N., Rao, K.R., and Ibrahim, A.B. 1972. Science 178: 1300.PubMedCrossRefGoogle Scholar
  7. 7.
    Dreesman, G.R., Hollinger, F.B., McCombs, R.M., and Melnick, J.L. 1973. J. Gen. Virol. 19: 129.PubMedCrossRefGoogle Scholar
  8. 8.
    Milich, D.R., McLachlan, A., Chisari, F.V., and Thornton, G.B. 1986. J. Exp. Med. 164: 532.PubMedCrossRefGoogle Scholar
  9. 9.
    Milich, D.R., Leroux-Roels, G.G., Louie, R.E., and Chisari, F.V. 1984. J. Exp. Med. 159: 41–56.PubMedCrossRefGoogle Scholar
  10. 10.
    Milich, D.R., Peterson, D.L., Leroux-Roels, G.G., Lerner, R.A., and Chisari, F.V. 1985. J. Immunol. 134: 4203.PubMedGoogle Scholar
  11. 11.
    Checka, J.M., Stratton, J.A., Miller, A., and Sercarz, E. 1976. Eur. J. Immunol. 6: 639.CrossRefGoogle Scholar
  12. 12.
    Berzofsky, J.A., Richman, L.K., and Killon, D.J. 1979. Proc. Natl. Acad. Sci. USA 76: 4046.PubMedCrossRefGoogle Scholar
  13. 13.
    Compos-Neto, A., Levine, H., and Schlossman, S.F. 1982. Cell. Immunol. 69: 128.CrossRefGoogle Scholar
  14. 14.
    Bersofsky, J.A. 1983. T-B reciprocity. Surv. Immunol. Res. 2: 223.Google Scholar
  15. 15.
    Milich, D.R., McLachlan, A., Chisari, F.V., Kent, S.B.H., and Thornton, G.B. 1986. J. Immunol. 137: 315.PubMedGoogle Scholar
  16. 16.
    Milich, D.R., McLachlan, A., Chisari, F.V., Nakamura, T., and Thornton, G.B. 1986. J. Immunol. 137: 2703.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • David R. Milich
    • 1
  • Alan McLachlan
    • 1
  • George B. Thornton
    • 2
  1. 1.Department of Basic and Clinical ResearchScripps Clinic and Research FoundationLa JollaUSA
  2. 2.Johnson and Johnson Biotechnology Center, Inc.San DiegoUSA

Personalised recommendations